Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases.

Alexiou A, Nizami B, Khan FI, Soursou G, Vairaktarakis C, Chatzichronis S, Tsiamis V, Manztavinos V, Yarla NS, Md Ashraf G.

Curr Protein Pept Sci. 2018;19(9):850-857. doi: 10.2174/1389203718666170810150151. Review.

PMID:
28799502
2.

Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention.

Briston T, Hicks AR.

Biochem Soc Trans. 2018 Aug 20;46(4):829-842. doi: 10.1042/BST20180025. Epub 2018 Jul 9. Review.

3.

Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.

Hashimoto M, Rockenstein E, Crews L, Masliah E.

Neuromolecular Med. 2003;4(1-2):21-36. Review.

PMID:
14528050
4.

Cross-functional E3 ligases Parkin and C-terminus Hsp70-interacting protein in neurodegenerative disorders.

Kumar P, Pradhan K, Karunya R, Ambasta RK, Querfurth HW.

J Neurochem. 2012 Feb;120(3):350-70. doi: 10.1111/j.1471-4159.2011.07588.x. Epub 2011 Dec 21. Review.

5.

Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.

Gu Z, Nakamura T, Lipton SA.

Mol Neurobiol. 2010 Jun;41(2-3):55-72. doi: 10.1007/s12035-010-8113-9. Epub 2010 Mar 25. Review.

6.

Mitochondrial dynamics in cell death and neurodegeneration.

Cho DH, Nakamura T, Lipton SA.

Cell Mol Life Sci. 2010 Oct;67(20):3435-47. doi: 10.1007/s00018-010-0435-2. Epub 2010 Jun 25. Review.

PMID:
20577776
7.

Structural studies of parkin and sacsin: Mitochondrial dynamics in neurodegenerative diseases.

Li X, Gehring K.

Mov Disord. 2015 Oct;30(12):1610-9. doi: 10.1002/mds.26357. Epub 2015 Sep 11. Review.

PMID:
26359782
8.

Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease.

Chouhan AK, Guo C, Hsieh YC, Ye H, Senturk M, Zuo Z, Li Y, Chatterjee S, Botas J, Jackson GR, Bellen HJ, Shulman JM.

Acta Neuropathol Commun. 2016 Jun 23;4(1):62. doi: 10.1186/s40478-016-0333-4.

9.

Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein.

Moussa CE.

J Mol Neurosci. 2009 Jan;37(1):25-36. doi: 10.1007/s12031-008-9099-x. Epub 2008 Jun 17. Erratum in: J Mol Neurosci. 2009 Mar;37(3):301.

PMID:
18561034
10.

Oxidative species-induced excitonic transport in tubulin aromatic networks: Potential implications for neurodegenerative disease.

Kurian P, Obisesan TO, Craddock TJA.

J Photochem Photobiol B. 2017 Oct;175:109-124. doi: 10.1016/j.jphotobiol.2017.08.033. Epub 2017 Aug 24.

11.

Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses.

Wilkaniec A, Czapski GA, Adamczyk A.

J Neurochem. 2016 Jan;136(2):222-33. doi: 10.1111/jnc.13365. Epub 2015 Oct 14. Review.

12.

Amyloid β-42 induces neuronal apoptosis by targeting mitochondria.

Han XJ, Hu YY, Yang ZJ, Jiang LP, Shi SL, Li YR, Guo MY, Wu HL, Wan YY.

Mol Med Rep. 2017 Oct;16(4):4521-4528. doi: 10.3892/mmr.2017.7203. Epub 2017 Aug 10.

13.

Appoptosin interacts with mitochondrial outer-membrane fusion proteins and regulates mitochondrial morphology.

Zhang C, Shi Z, Zhang L, Zhou Z, Zheng X, Liu G, Bu G, Fraser PE, Xu H, Zhang YW.

J Cell Sci. 2016 Mar 1;129(5):994-1002. doi: 10.1242/jcs.176792. Epub 2016 Jan 26.

14.

Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.

Majd S, Power JH, Grantham HJ.

BMC Neurosci. 2015 Oct 23;16:69. doi: 10.1186/s12868-015-0211-1. Review.

15.

Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.

Gadad BS, Britton GB, Rao KS.

J Alzheimers Dis. 2011;24 Suppl 2:223-32. doi: 10.3233/JAD-2011-110182. Review.

PMID:
21460436
16.

Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.

Dohm CP, Kermer P, Bähr M.

Neurodegener Dis. 2008;5(6):321-38. doi: 10.1159/000119459. Epub 2008 Feb 29. Review.

PMID:
18309232
17.

Mitochondrial fusion/fission dynamics in neurodegeneration and neuronal plasticity.

Bertholet AM, Delerue T, Millet AM, Moulis MF, David C, Daloyau M, Arnauné-Pelloquin L, Davezac N, Mils V, Miquel MC, Rojo M, Belenguer P.

Neurobiol Dis. 2016 Jun;90:3-19. doi: 10.1016/j.nbd.2015.10.011. Epub 2015 Oct 19. Review.

PMID:
26494254
18.

[Neurodegenerative conformational disease and its molecular bases].

Li WW, Cai DF, Ren HM.

Sheng Li Ke Xue Jin Zhan. 2006 Apr;37(2):97-102. Review. Chinese.

PMID:
16850610
19.

Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

Kandimalla R, Manczak M, Fry D, Suneetha Y, Sesaki H, Reddy PH.

Hum Mol Genet. 2016 Nov 15;25(22):4881-4897. doi: 10.1093/hmg/ddw312.

Supplemental Content

Support Center